乳腺癌
重编程
基因
计算生物学
生物
鉴定(生物学)
基因表达
癌症
转录组
基因表达谱
生物信息学
代谢途径
代谢网络
小RNA
基因表达调控
癌症研究
生物标志物
代谢组学
基因组
精密医学
诊断生物标志物
癌症治疗
细胞周期
医学
通路分析
遗传学
转录因子
生物途径
作者
Husheng Kong,Mengyuan Pan,Li Sun
标识
DOI:10.1007/s10238-025-01870-1
摘要
Triple-negative breast cancer (TNBC) is notorious for its rapid progression, tendency to metastasize, high recurrence rates, dismal outcomes, and limited treatment options, underscoring the urgent need to uncover new biomarkers and molecular pathways to enhance diagnosis, prognosis, and therapeutic strategies. Metabolic reprogramming continues to play a role throughout the life cycle of cancer, evolving and adapting. In this study, we aimed to identify specific genes associated with metabolic reprogramming in TNBC, which can potentially become unique biomarkers of this cancer. TNBC datasets retrieved from the Gene Expression Omnibus were employed to pinpoint genes exhibiting altered expression linked to tumor metabolic reprogramming. Key genes were accurately screened through machine learning algorithms, and then externally verified using the TBNC dataset based on the Cancer Genome Atlas database. Finally, immunohistochemical methods were used to clinically confirm the differential expression and trends of these key genes. Our analysis accurately identified four genes-CLEC7A, IRS1, RSPO3, and ALB-that are closely correlated with the metabolic reprogramming characteristics of cancer, and could be regarded as innovative biomarkers for TNBC. This opens a new avenue for further investigation into the mechanisms of metabolic reprogramming in TNBC and new treatment strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI